OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 37 filers reported holding OPIANT PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,215,644 | +47.7% | 59,943 | -21.7% | 0.32% | +38.5% |
| Q3 2022 | $823,000 | -9.3% | 76,530 | +1.2% | 0.23% | -29.9% |
| Q2 2022 | $907,000 | +30.1% | 75,632 | +132.3% | 0.33% | +63.7% |
| Q1 2022 | $697,000 | -33.7% | 32,557 | +4.0% | 0.20% | -12.1% |
| Q4 2021 | $1,052,000 | +36.3% | 31,291 | +4.3% | 0.23% | +19.0% |
| Q3 2021 | $772,000 | – | 30,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 210,000 | $2,518,000 | 5.80% |
| APIS CAPITAL ADVISORS, LLC | 196,000 | $2,350,000 | 2.65% |
| Stonepine Capital Management, LLC | 152,278 | $1,826,000 | 0.85% |
| Parkman Healthcare Partners LLC | 75,632 | $907,000 | 0.33% |
| PERRITT CAPITAL MANAGEMENT INC | 30,500 | $366,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 50,405 | $604,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 126,978 | $1,523,000 | 0.01% |
| Trexquant Investment LP | 12,219 | $147,000 | 0.01% |
| Renaissance Technologies | 193,415 | $2,319,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 74,400 | $892,000 | 0.00% |